Evidence map›Paper›PMID 42201370›Full record

ArticleRadiologie (Heidelberg, Germany)2026

[Detection and differentiation of atypical hepatocellular carcinomas].

Chiraz Ben-Salah, Philipp Mayer, Thomas Longerich, Miriam Klauß

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Radiologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chiraz Ben-SalahKlinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Deutschland.
Philipp MayerKlinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Deutschland.
Thomas LongerichPathologisches Institut, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.
Miriam KlaußKlinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Deutschland. Miriam.klauss@med.uni-heidelberg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is a histologically heterogeneous tumor entity. According to the current World Health Organization (WHO) classification in addition to not otherwise specified (NOS) HCCs it is comprised of eight subtypes: steatohepatitic, clear cell, macrotrabecular massive, scirrous, chromophobe, fibrolamellar, granulocyte-rich and lymphocyte-rich. The HCC diagnosis is based on typical contrast agent behavior with arterial hyperenhancement followed by washout; however, HCC subtypes can show additional imaging features related to their histology. In addition, the HCC subtypes can partially differ from NOS HCC in aggressiveness and prognosis. Characterizing the various HCC subtypes could enable individualized treatment in the future and thus potentially influence the prognosis, even though a subtype-specific treatment for HCC subtypes apart from in studies is not currently available.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsContrast MediaDiagnosis, DifferentialHumansMagnetic Resonance ImagingContrast MediaHCC subtypesLI-RADSLiver lesionLiver neoplasmsMagnetic resonance imaging

Identifiers

PMID42201370

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.